CAPULLI, MATTIA
 Distribuzione geografica
Continente #
NA - Nord America 1.967
EU - Europa 1.123
AS - Asia 688
SA - Sud America 4
OC - Oceania 2
Totale 3.784
Nazione #
US - Stati Uniti d'America 1.964
IE - Irlanda 332
CN - Cina 305
TR - Turchia 186
DE - Germania 168
SG - Singapore 167
SE - Svezia 152
IT - Italia 134
UA - Ucraina 115
GB - Regno Unito 103
FI - Finlandia 48
FR - Francia 43
VN - Vietnam 12
BE - Belgio 10
IN - India 6
CZ - Repubblica Ceca 5
NL - Olanda 4
RU - Federazione Russa 4
BR - Brasile 2
CA - Canada 2
ID - Indonesia 2
JP - Giappone 2
KR - Corea 2
TH - Thailandia 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AT - Austria 1
AU - Australia 1
BO - Bolivia 1
CH - Svizzera 1
IL - Israele 1
KZ - Kazakistan 1
LV - Lettonia 1
MX - Messico 1
NZ - Nuova Zelanda 1
PE - Perù 1
PL - Polonia 1
RO - Romania 1
Totale 3.784
Città #
Jacksonville 446
Chandler 375
Dublin 332
Boardman 163
Singapore 142
Santa Clara 125
Izmir 99
Nanjing 91
San Mateo 77
Ann Arbor 63
Lawrence 59
Princeton 59
Wilmington 56
Ashburn 53
New York 36
L'aquila 35
Milan 32
Nanchang 29
Woodbridge 26
Bremen 25
Beijing 23
Guangzhou 21
Seattle 21
Kitzingen 20
Tianjin 19
Shenyang 18
L’Aquila 13
Dearborn 12
Dong Ket 12
Verona 11
Brussels 10
Hebei 10
Jinan 10
Mountain View 10
Norwalk 10
Des Moines 9
Kunming 8
Jiaxing 7
Los Angeles 6
Washington 6
Aquila 5
Dallas 5
Falls Church 5
Lanzhou 5
Shanghai 5
Brno 4
Changsha 4
Fremont 4
Ningbo 4
Redmond 4
Shangdi 4
Strasbourg 4
Zhengzhou 4
Changchun 3
Fuzhou 3
Harbin 3
Pune 3
Auburn Hills 2
Chongqing 2
Fairfield 2
Helsinki 2
Houston 2
Munich 2
Nerviano 2
Pisa 2
Regensburg 2
Rome 2
Sumter 2
Taizhou 2
Torre Del Greco 2
West Jordan 2
Almaty 1
Amsterdam 1
Auckland 1
Bangkok 1
Baotou 1
Bellante 1
Cedar Knolls 1
Chicago 1
Cividate al Piano 1
Denpasar 1
Dubai 1
Edinburgh 1
Galliate 1
Grafing 1
Guiyang 1
Haikou 1
Hangzhou 1
Hanover 1
Hefei 1
Hitzkirch 1
Kaifeng 1
La Paz 1
Lanciano 1
Leipzig 1
Lima 1
London 1
Manoppello 1
Martino 1
Mesa 1
Totale 2.705
Nome #
Tumor-stroma metabolic relationship based on lactate shuttle can sustain prostate cancer progression 110
Biotechnological approach for systemic delivery of membrane Receptor Activator of NF-κB Ligand (RANKL) active domain into the circulation 106
A gene expression signature from bone metastases as predictor of clinical outcome in breast cancer patients 98
Interleukin-1β, lipocalin 2 and nitric oxide synthase 2 are mechano-responsive mediators of mouse and human endothelial cell-osteoblast crosstalk 91
The N-terminal domain of the bone protein PRoline/arginine-rich End Leucine-rich repeat Protein (PRELP) impairs osteoclast formation by a new mechanism inhibiting NF-kappaB signaling 87
Generation of the first autosomal dominant osteopetrosis type II (ADO2) disease models 83
A COMPLEX ROLE FOR LIPOCALIN 2 IN BONE METABOLISM: GLOBAL ABLATION IN MICE INDUCES OSTEOPENIA CAUSED BY AN ALTERED ENERGY METABOLISM 83
RNA interference therapy for autosomal dominant osteopetrosis type 2. Towards the preclinical development 82
Effective small interfering RNA therapy to treat CLCN7-dependent autosomal dominant osteopetrosis type 2 81
SMALL INTERFERING RNA (siRNA) FOR THE THERAPY OF TYPE 2 (ADO2) AUTOSOMAL DOMINANT OSTEOPETROSIS CAUSED BY CLCN7 (ADO2 CLCN7-DEPENDENT) GENE MUTATION 81
The C-terminal domain of chondroadherin: a new regulator of osteoclast motility counteracting bone loss 80
The α2β1 binding domain of chondroadherin inhibits breast cancer-induced bone metastases and impairs primary tumour growth: A preclinical study 80
Bone-Targeted Doxorubicin-Loaded Nanoparticles as a Tool for the Treatment of Skeletal Metastases 80
Global Transcriptome Analysis in Mouse Calvarial Osteoblasts Highlights Sets of Genes Regulated by Modeled Microgravity and Identifies A "Mechanoresponsive Osteoblast Gene Signature" 77
Non-conventional role of haemoglobin beta in breast malignancy 76
The glycosaminoglycan-binding domain of PRELP acts as a cell type-specific NF-kappaB inhibitor that impairs osteoclastogenesis 74
TRAF2 in osteotropic breast cancer cells enhances skeletal tumour growth and promotes osteolysis. 74
the effect of microgravity on osteoblast metabolism 72
An experimental therapy to improve skeletal growth and prevent bone loss in a mouse model overexpressing IL-6 71
beta-Arrestin2 Regulates RANKL and Ephrins Gene Expression in Response to Bone Remodeling in Mice 70
c-Src-mediated regulation of Penk1 signal controls osteoblast differentiation 67
Lipocalin 2: A New Mechanoresponding Gene Regulating Bone Homeostasis 67
The matrix PROLINE/Arginine-Rich end leucin-rich repeat protein (PRELP) impairs osteoclastogenesis by inhibiting NF-kappaB activity 65
ENERGY METABOLISM OF PROSTATE CANCER CAN BE SUPPORTED BY REVERSE WARBURG EFFECT 64
Improvement of the skeletal phenotype in a mouse model of diastrophic dysplasia after postnatal treatment with N-acetylcysteine 63
The N-terminal domain of the bone protein PRoline/arginine-rich End Leucine-rich repeat Protein (PRELP) impairs osteoclast formation by a new mechanism inhibiting NF-kappaB signaling 60
EFFECTS OF 1D11 AN ANTIBODY AGAINST TRANSFORMING GROWTH FACTOR BETA (TGF-B) ON INCIDENCE AND LOCAL GROWTH OF PROSTATE CANCER BONE METASTASES 60
EFFECTS OF DUAL PI3K AND mTOR INHIBITION ON INCIDENCE AND LOCAL GROWTH OF PROSTATE CANCER BONE METASTASES 60
Increased expression of a set of genes enriched in oxygen binding function discloses a predisposition of breast cancer bone metastases to generate metastasis spread in multiple organs 60
Lipocalin 2 is a novel mechanoresponding gene involved in osteoblast differentiation and osteoblast-osteoclast cross-talk 59
Extra-skeletal manifestations in mice affected by Clcn7-dependent autosomal dominant osteopetrosis type 2 clinical and therapeutic implications 59
Paradoxical effects of JZL184, an inhibitor of monoacylglycerol lipase, on bone remodelling in healthy and cancer-bearing mice 58
Osteoblast and osteocyte: games without frontiers 57
Generation and culture of osteoclasts. 57
Testing the Cre-mediated genetic switch for the generation of conditional knock-in mice 57
Gene microarray analysis in mouse osteoblasts reveals sets of relevant mrnas regulated under modeled microgravity 56
Role of RAMP2 and BSP2 in the c-Src-regulated osteomimicry of breast cancer bone metastasis 55
The molecular switch NHERF1 induces tumour phenotypic changes associated with distinct metastatic organotropism in breast cancer via its PDZ domains 54
Microarray Analysis of Human Bone Metastases Evidenced a Set of Genes that Segregates Patients with Metastases only in Bone from Patients with Metastases also in Visceral Organs 54
Osteoblasts Regulate Angiogenesis in Response to Mechanical Unloading 54
Systemic and local determinants contribute to the bone phenotype in duchenne muscular dystrophy 53
Pre-clinical employment of the heparin binding domain of PRELP in the treatment of bone loss diseases 52
NHERF1 acts as a molecular switch to program metastatic behavior and organotropism via its PDZ domains 52
Proline/arginine-rich end leucine-rich repeat protein N-terminus is a novel osteoclast antagonist that counteracts bone loss 52
Mechanisms inducing low bone density in Duchenne Muscular Dystrophy 51
Lipocalin2 is a new regulator of osteoblast functions in response to mechanical forces 51
The Matrix PRoline/arginine-rich End Leucine-rich Repeat Protein (PRELP) Interferes with the NF-kappaB Pathway and Impairs Osteoclast Formation and Activity 51
Sets of genes are regulated in osteoblasts by modelled microgravity 51
Global Transcriptome Analysis in Mouse Osteoblasts Identifies a Mechanosensing Osteoblast Gene Signature 51
Mechanisms underlying low bone density in muscular dystrophy 50
Up-regulation of a set of genes in breast cancer bone metastases discloses predisposition to generate metastases also in visceral organs 50
A new therapeutic approach to prevent oestrogen-withdrawal induced bone loss 49
Notch2 pathway mediates breast cancer cellular dormancy and mobilisation in bone and contributes to haematopoietic stem cell mimicry 49
MECHANISMS INDUCING LOW BONE DENSITY IN DUCHENNE MUSCULAR DYSTROPHY 48
NHERF1 programs invasive and metastatic behaviours in breast tumor cells 48
CRELD2 Is a Novel LRP1 Chaperone That Regulates Noncanonical WNT Signaling in Skeletal Development 45
Mechanisms Inducing Low Bone Density in Duchenne Muscular Dystrophy in Mice and Humans 44
Regulation of breast cancer induced bone disease by cancer-specific IKKβ 41
Combined administration of a small-molecule inhibitor of TRAF6 and Docetaxel reduces breast cancer skeletal metastasis and osteolysis 41
Multidisciplinary investigation of an ancient renal stone in a mummy from Popoli, central Italy 31
Small interfering RNA (siRNA) for the therapy of type 2 (ADO2) Autosomal Dominant Oosteopetrosis caused by CLCN7 (ADO2 CLCN7-dependent) gene mutation 24
A neuronal action of sirtuin 1 suppresses bone mass in young and aging mice 17
Totale 3.843
Categoria #
all - tutte 16.837
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.837


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020338 0 0 0 0 0 93 95 2 60 15 4 69
2020/2021506 15 66 0 64 61 15 65 3 60 23 106 28
2021/2022325 19 30 63 22 15 4 10 16 17 8 33 88
2022/20231.029 74 55 12 125 121 111 1 62 419 6 29 14
2023/2024283 33 20 24 40 25 66 0 17 1 4 4 49
2024/2025426 14 20 112 42 141 97 0 0 0 0 0 0
Totale 3.843